KELOWNA, BC / March 11, 2015 / Lexaria Corp. (LXRP) (CSE: LXX) will be presenting at the Cannabis Investor Webcast on Thursday, March 12, 2015 at 11:00 AM ET.
“We’re excited that Lexaria Corp. has decided to present to our online audience of investors, analysts, executives, media, and consumers,” said Derwin A. Wallace, Senior VP of Investor Webcast. “The online interactive webcast will assist Lexaria Corp. in increasing its awareness and exposure.”
The Cannabis Investor Webcast will include presentations from privately-held and publicly-traded industry companies and industry professionals. Lexaria’s presentation will be 30-minutes long and followed by 15-minutes of Q&A. The Cannabis Investor Webcast is a great opportunity for the audience to research industry companies without taking time-off from work, paying registration fees and incurring travel-related expenses.
“The Cannabis Investor Webcast will provide Lexaria Corp, an online interactive platform that will give us an opportunity to provide an overview of our company and its recent developments to investors, media and the general public,” states Chris Bunka, President of Lexaria Corp.
Cannabis investors, analysts, executives, media, and consumers who would like to attend the free online webcast please click on the link http://www.cannawebcast.com/ and visit our Registration Page. To view the recording of the webcast please visit www.youtube.com and search for Cannabis Investor Webcast two weeks after the live presentation.
About Lexaria Corp.
Lexaria’s shares are quoted in the USA with the symbol LXRP and in Canada with the symbol LXX. The company searches for projects that could provide potential above-market returns.
To learn more about Lexaria Corp. visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). PoViva products are not intended to diagnose, treat, cure or prevent any disease.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
